David A. Bushinsky

Hospital-acquired renal insufficiency: A prospective study

Susan Hou, David A. Bushinsky, Jay B. Wish et al. · The American Journal of Medicine · 1983 · 1.2K citations

Medicine, Nephrology, Urology +9

Patiromer in Patients with Kidney Disease and Hyperkalemia Receiving RAAS Inhibitors

Matthew R. Weir, George L. Bakris, David A. Bushinsky et al. · New England Journal of Medicine · 2014 · 658 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Effect of Patiromer on Serum Potassium Level in Patients With Hyperkalemia and Diabetic Kidney Disease

George L. Bakris, Bertram Pitt, Matthew R. Weir et al. · JAMA · 2015 · 437 citations

Medicine, Pharmacology, Pharmacotherapy +16

Evaluation of the efficacy and safety of RLY5016, a polymeric potassium binder, in a double-blind, placebo-controlled study in patients with chronic heart failure (the PEARL-HF) trial

Bertram Pitt, Stefan D. Anker, David A. Bushinsky et al. · European Heart Journal · 2011 · 437 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Sustained, Long-Term Renal Stabilization After 54 Months of Agalsidase β Therapy in Patients with Fabry Disease

Dominique P. Germain, Stephen Waldek, Maryam Banikazemi et al. · Journal of the American Society of Nephrology · 2007 · 435 citations

Medicine, Clinical Sciences, Pharmacotherapy +9